PLATINO, a nine-year follow-up study of COPD in the city of São Paulo, Brazil: the problem of underdiagnosis

• Published in: Jornal brasileiro de pneumologia 2014-01, Vol.40 (1), p.30-37
• Main Authors: Moreira, Graciane Laender, Manzano, Beatriz Martins, Gazzotti, Mariana Rodrigues, Nascimento, Oliver Augusto, Perez-Padilla, Rogelio, Menezes, Ana Maria Baptista, Jardim, José Roberto
• Format: Article
• Language: eng ; por
• Subjects: Aged; Body Mass Index; Brazil - epidemiology; Doenca pulmonar obstrutiva cronica/diagnostico; Doenca pulmonar obstrutiva cronica/epidemiologia; Espirometria; Female; Follow-Up Studies; Health Surveys; Humans; Male; Middle Aged; Original; Pulmonary Disease, Chronic Obstructive - diagnosis; Pulmonary Disease, Chronic Obstructive - epidemiology; RESPIRATORY SYSTEM; Socioeconomic Factors; Spirometry; Surveys and Questionnaires; Urban Population
• ISSN: 1806-3713; 1806-3756; 1806-3756
• DOI: 10.1590/S1806-37132014000100005

To determine the underdiagnosis rate in new COPD cases at the end of a nine-year follow-up period-in the study designated "Projeto Latino-Americano de Investigação em Obstrução Pulmonar" (PLATINO, Latin-American Pulmonary Obstruction Investigation Project)-and compare that with the underdiagnosis rate during the initial phase of the study, as well as to identify the clinical features exhibited by the subjects who were not diagnosed until the end of the follow-up phase. The study population comprised the 1,000 residents of the city of São Paulo, Brazil, who took part in the PLATINO study. Of those, 613 participated in the follow-up phase, during which the subjects were assessed with the same instruments and equipment employed in the initial phase of the study. We used the chi-square test or the independent sample t-test to analyze the underdiagnosis rate and to identify the characteristics of the subjects who were not diagnosed until the end of the follow-up phase. The underdiagnosis rate for new COPD cases at the end of the nine-year follow-up period was 70.0%. The underdiagnosis rate during the follow-up phase was 17.5% lower than that reported for the initial phase of the study. The subjects who were not diagnosed until the end of the follow-up phase presented with fewer respiratory symptoms, better pulmonary function, and less severe disease than did those previously diagnosed with COPD. The underdiagnosis rate for new COPD cases was lower in the follow-up phase of the study than in the initial phase. The subjects who were not diagnosed until the end of the follow-up phase of the PLATINO study presented with the same clinical profile as did those who were not diagnosed in the initial phase. These findings underscore the need for spirometry in order to confirm the diagnosis of COPD and provide early intervention.